Vanguard Capital Management’s Journey Medical DERM Stock Holding History
Bought
Maintained
Sold
Other funds holding DERM
Vanguard Capital Management's DERM Position: Q3 2026 in Review
Vanguard Capital Management held its Journey Medical (DERM) position steady in Q3 2026 at 675,185 shares worth $4.62M. The position accounts for ﹤0.01% of the portfolio, ranked #3109.
Vanguard Capital Management first reported a position in DERM in Q1 2026 and has held it in 3 quarters since. The position peaked at $5.07M in Q1 2026. 48 funds tracked by Wall St. Rank hold DERM as of Q3 2026.
- Vanguard Capital Management held 675,185 shares of Journey Medical worth $4.62M as of Q3 2026.
- Vanguard Capital Management left its Journey Medical share count unchanged in Q3 2026.
- Journey Medical made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3109 holding.
- Vanguard Capital Management first reported a position in Journey Medical in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's Journey Medical position peaked at $5.07M in Q1 2026.
- 48 funds tracked by Wall St. Rank held Journey Medical as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.